Medicalgorithmics SA stock news
Medicalgorithmics SA has received an additional order for its Kardiobeat.ai devices from its Canadian partner, a subsidiary of a global American diagnostics company. The order is valued at USD 500,000 (approximately PLN 1.8 million) and is scheduled for fulfillment in 2026. This expansion increases the total contractually guaranteed minimum revenue from the partnership to USD 6.4 million (approximately PLN 23.1 million) through March 2028.